Product Images Argatroban

This appears to be a table or chart displaying laboratory results, with headings for two tests: W aPTT (a blood test used to monitor heparin therapy) and Plasma Argatroban (a test to monitor anticoagulant therapy with Argatroban). The results for each test have been measured at various intervals, with corresponding infusion doses. However, without additional context it is difficult to provide a more specific description of the purpose or implications of these results.*

This document seems to be a comparison between two treatments for blood clotting: INR Warfarin Plus Argatroban (WA) and INR Warfarin Alone (W). There is no further information available to give a more specific description or context.*

This is a description of a study with a historical control group of 147 individuals, 90 of which were censored. The results show a proportion of event-free days and a p value of 0.007. The study period had a maximum follow-up of 37 days and no clinical endpoints (death, amputation, or new thrombosis) were observed during this period.*

The data presented appears to be related to a comparison between the effectiveness of Argatroban and a Historical Control. The sample size (N), number of censored cases, and p-value are reported. The x-axis seems to represent different study days, while the y-axis may represent the proportion of event-free cases. The text also clarifies that "censored" denotes cases where no clinical endpoint was observed during the follow-up period.*